BioNet News, Events 15 Jan 2026 The European Commission Grants Marketing Authorisation for a First-of-its-Kind Pertussis-Only Vaccine for Vaccination of Teenagers, Adults and Pregnant Women in the European Union Supachai
BioNet News, Events 21 Nov 2025 BioNet Receives Positive CHMP Opinion from EMA for VacPertagen, a Recombinant Vaccine Against Pertussis Bangkok, November 21, 2025 - BioNet, a biotechnology company dedicated to innovative vaccines, announced today that the Committee for Medicinal… Supachai
BioNet News, Events 17 Nov 2025 BioNet Achieves EU-GMP Certification for its Pertussis Vaccine Manufacturing Lyon, France – October 29, 2025, BioNet today announced it has received European Union Good Manufacturing Practice (EU-GMP) certification, an… Pantitra
BioNet News, Events 03 Sep 2025 Clinical Study on Reduced-Dose Pertussis Vaccine in Thailand In collaboration with Faculty of Medicine, Chulalongkorn University, BioNet has advanced a clinical study on a next-generation pertussis vaccine, featuring… Pantitra
BioNet News, Events 01 Sep 2025 Running with Heart, Driven by Values On August 24, BioNet joined the 6th HITECH RUN 2025 at Hi-Tech Industrial Estate in Ayutthaya. This was more… Pantitra
BioNet News, Events 19 Jun 2025 Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy Both the quantity and quality of circulating anti-pertussis toxin antibodies are important for protection against severe pertussis. We compared the… Pantitra
BioNet News, Events 12 Jun 2025 Meet BioNet at APS-MCV 2025 | Advancing Pertussis Protection Together Join us at the Asia-Pacific Summit on Medical and Clinical Vaccinology (APS-MCV) during June 14-15, 2025 in Taipei as we… Pantitra
